While Lpcat3 macrophage deficiency did not affect atherosclerosis development, Lpcat3KOMac mice presented with a mild increase in hepatic steatosis under a high-fat diet (HFD) that was associated with alterations of several metabolic pathways and liver eicosanoid composition. This evidence concerns the gene LPCAT3 and fatty liver disease.